Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) EBT Margin: 2022-2025

Historic EBT Margin for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -362.73%.

  • Gossamer Bio's EBT Margin fell 2586.00% to -362.73% in Q3 2025 from the same period last year, while for Sep 2025 it was -795.81%, marking a year-over-year decrease of 62729.00%. This contributed to the annual value of -61.34% for FY2024, which is 139223.00% down from last year.
  • Latest data reveals that Gossamer Bio reported EBT Margin of -362.73% as of Q3 2025, which was down 13.74% from -318.90% recorded in Q2 2025.
  • Gossamer Bio's EBT Margin's 5-year high stood at 1,698.73% during Q3 2022, with a 5-year trough of -397.03% in Q1 2025.
  • Its 3-year average for EBT Margin is 525.74%, with a median of 242.37% in 2024.
  • Data for Gossamer Bio's EBT Margin shows a maximum YoY tumbled of 182,700bps (in 2025) over the last 5 years.
  • Gossamer Bio's EBT Margin (Quarterly) stood at 1,655.19% in 2022, then crashed by 16,868bps to 1,486.51% in 2023, then slumped by 124,414bps to 242.37% in 2024, then crashed by 2,586bps to -362.73% in 2025.
  • Its last three reported values are -362.73% in Q3 2025, -318.90% for Q2 2025, and -397.03% during Q1 2025.